Carsten Thiel – Pharmaceutical And Biopharmaceutical Expert


Carsten Thiel was born in Berlin where he grew up, studied during his youth and finally joined Malbrook to study Chemistry. Later, he left for the United Kingdom to study organic chemistry at the University of Bristol where he graduated with a Bachelor of Science and decided to major in Biochemistry.

Carsten Thiel advanced his studies by taking his PhD in molecular biology at Max Planck Institute for Biophysical Chemistry. After completing his studies, Thiel joined the world of pharmaceuticals through Hoffman La-Roche, a biotechnology firm. He started as the communications and product manager where he displayed his prowess and was later promoted to the departments of scientific marketing and market assessment.

Carsten has been very impactful in the field of Biochemistry. He has integrated his experience, leadership and profession to oversee the launch of several high-profile medical products. Thiel’s involvement in medicine has also improved the lives of many patients through improving patient care, provider-patient relationship and upholding medical ethics.

He spearheaded the launch of Xenical, a weight loss product. This came as his first venture in the marketing sector for masses although he had been marketing vitamins and other fine chemicals to medical providers. Thiel’s efforts bore fruits and he saw the successful launch of Xenical. He focused on launching it with the right stakeholders and particular group of customers who would really benefit from its use. Though the method did not guarantee many sales, Thiel convinced Roche’s leadership to back him. They were then successful and able to earn over a billion Swiss Francs from the sale of Xenical within a year. View Related Info Here.

After Xenical, Carsten Thiel was also involved in the launch of Vectibix, a medicine for colorectal cancer. He also gone to oversee the creation of symbiotic relationships between business success, uphold of medical ethics and patient satisfaction.




How Carsten Thiel And Other Biotech Experts Help Create New Medical Therapies


The world of Biotechnology has been responsible for some of the biggest breakthroughs in the medical world. Thanks to the work of experts like Carsten Thiel, these breakthroughs have become more accessible to patients around the world.

Carsten Thiel is an authority in biotechnology having spent a good number of years in the industry.

Carsten Thiel has a Ph.D and was the CEO of Abeona Therapeutics Inc. This is a biopharmaceutical company for clinical-stages that mainly develops gene and cell therapies for genetic diseases that are rare and life-threatening. It is a company that is a major part of the golden age of biotechnology that Carsten Thiel is very much a part of.

Here is how Biotech has rapidly changed the world

First, NDA sequencing has become more accessible than ever. When the first human genome was sequenced in 1995, the cost of that project has exceeded $2 billion dollars. Carsten Thiel worked hard to bring the price down to about $1,000. This makes it easier for more patients to get the specific treatments they need.

Second, the innovations of Biotech have made it easier for medical professionals to understand how the human body works. Experts like Carsten Thiel and others have been able to better engineer medical therapies based on gene editing and other Biotech innovations. These breakthroughs have allowed for the development of important drugs such as proton pump antagonists, ACE inhibitors, Statins, and histamine receptor antagonists.

Finally, the breakthroughs in the Biotech industry has created a larger tool kit for medical professionals to use to treat their patients. Carsten Thiel and other Biotech executives have brought to marker a number of therapies including gene therapy and regenerative cell therapies and nanoparticle delivery systems. See This Page to learn more.

Going forward, the Biotech world will continue to innovative the world of Biotech. Led by Carsten Thiel and others, new medical therapies will be coming in the next decade. And these therapies will help further increase the survivability of patients with complex medical issues.


Learn more  about Thiel on